ArticleCardiovascular diabetology2024

Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention.

Eun Ho Choo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.